Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution.

Silicone oil, which is used as a lubricant or coating in devices such as syringes, needles and pharmaceutical containers, has been implicated in aggregation and particulation of proteins and antibodies. Aggregation of therapeutic protein products induced by silicone oil can pose a challenge to their development and commercialization. To systematically characterize the role of silicone oil on protein aggregation, the effects of agitation, temperature, pH, and ionic strength on silicone oil-induced loss of monomeric anti-streptavidin IgG 1 antibody were examined. Additionally, the influences of excipients polysorbate 20 and sucrose on protein aggregation were investigated. In the absence of agitation, protein absorbed to silicone oil with approximately monolayer coverage, however silicone oil did not stimulate aggregation during isothermal incubation unless samples were also agitated. A synergistic stimulation of aggregation by a combination of agitation and silicone oil was observed. Solution conditions which reduced colloidal stability of the antibody, as assessed by determination of osmotic second virial coefficients, accelerated aggregation during agitation with silicone oil. Polysorbate 20 completely inhibited silicone oil-induced monomer loss during agitation. A formulation strategy involving optimization of colloidal stability of the antibody as well as incorporation of surfactants such as polysorbate 20 is proposed to reduce silicone oil-induced aggregation of therapeutic protein products.

[1]  A. Arabshahi,et al.  [6] Second virial coefficient as predictor in protein crystal growth. , 1997, Methods in enzymology.

[2]  M. Manning,et al.  Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. , 1998, Journal of pharmaceutical sciences.

[3]  Janice M Reichert,et al.  Monoclonal antibody successes in the clinic , 2005, Nature Biotechnology.

[4]  B. Chang,et al.  Mechanism for benzyl alcohol-induced aggregation of recombinant human interleukin-1 receptor antagonist in aqueous solution. , 2004, Journal of Pharmacy and Science.

[5]  J. Lee,et al.  The stabilization of proteins by sucrose. , 1981, The Journal of biological chemistry.

[6]  A George,et al.  Predicting protein crystallization from a dilute solution property. , 1994, Acta crystallographica. Section D, Biological crystallography.

[7]  C. R. Middaugh,et al.  Silicone oil induced aggregation of proteins. , 2005, Journal of pharmaceutical sciences.

[8]  E. Chantelau,et al.  POLLUTION OF INSULIN WITH SILICONE OIL, A HAZARD OF DISPOSABLE PLASTIC SYRINGES , 1985, The Lancet.

[9]  B. Chang,et al.  Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Manning,et al.  Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulation. , 2005, Journal of pharmaceutical sciences.

[11]  John F. Carpenter,et al.  Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.

[12]  Theodore W Randolph,et al.  Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony‐stimulating factor , 2003, Protein science : a publication of the Protein Society.

[13]  James W. Evans,et al.  Random and cooperative sequential adsorption , 1993 .

[14]  J L Cleland,et al.  Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. , 1998, Journal of pharmaceutical sciences.

[15]  J. Tamada,et al.  Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  W. Caughey,et al.  Infrared methods for study of hemoglobin reactions and structures. , 1994, Methods in enzymology.

[17]  M. Manning,et al.  Effects of Tween 20 and Tween 80 on the stability of Albutropin during agitation. , 2005, Journal of pharmaceutical sciences.

[18]  A. Rosenberg,et al.  Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.

[19]  R. Baldwin.  Contamination of Insulin by Silicone Oil: a Potential Hazard of Plastic Insulin Syringes , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[20]  J. Fuller.  European Community Concerted Action Programme in Diabetes (EURODIAB) , 1989, Diabetic medicine : a journal of the British Diabetic Association.

[21]  L. Stockwin,et al.  Antibodies as therapeutic agents: vive la renaissance! , 2003, Expert opinion on biological therapy.

[22]  E. Chantelau,et al.  Silicone Oil Released From Disposable Insulin Syringes , 1986, Diabetes Care.

[23]  M. Rykke,et al.  Effect of silicone oil on protein adsorption to hydroxyapatite in vitro and on pellicle formation in vivo. , 1990, Scandinavian journal of dental research.

[24]  Monya Baker,et al.  Upping the ante on antibodies , 2005, Nature Biotechnology.

[25]  W. Caughey,et al.  Protein secondary structures in water from second-derivative amide I infrared spectra. , 1990, Biochemistry.

[26]  R. K. Bernstein.  Clouding and Deactivation of Clear (Regular) Human Insulin: Association With Silicone Oil From Disposable Syringes? , 1987, Diabetes Care.

[27]  Theodore W Randolph,et al.  Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition. , 2002, Biochemistry.